查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1433533

细胞治疗市场规模、份额、趋势分析报告：按治疗类型、治疗领域、地区、细分市场预测，2024-2030

Cell Therapy Market Size, Share & Trends Analysis Report By Therapy Type (Autologous (Stem Cell Therapies, Non-stem Cell Therapies), Allogeneic), By Therapeutic Area, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10个工作天内

价格

细胞治疗市场成长与趋势：

Grand View Research, Inc.最新报告显示，预计到2030年，全球细胞治疗市场规模将达到200.7亿美元，2024年至2030年复合年增长率为22.66%。

市场相关人员对开拓先进的组织、基因和细胞治疗方法越来越感兴趣。研究界和公司继续大量投资培养和分离多种细胞类型，包括角质形成细胞、软骨细胞、软骨细胞、干细胞、真皮乳头细胞和上皮细胞，以开发新的治疗方法。

FDA 等监管机构透过倡议开发和核准先进治疗方法并限制不受监管的治疗方法，在市场成长中发挥关键作用。此外，直接细胞重编程由于其有效性和安全性等优势，作为一种尖端治疗方法而受到关注。

同时，与先进治疗相关的临床试验数量的增加预计将在未来几年推动市场成长。根据美国基因与细胞治疗学会获得的资料，2022年第一季启动了32项非重组细胞疗法临床试验，其中69%是非重组肿瘤领域。此外，根据 ClinicalTrials.gov 的数据，超过 1,800 种细胞疗法正在进行临床试验。

此外，市场上营运的主要企业正在采取多项策略倡议，例如各种协议、新产品推出和业务扩展，以增强其在市场上的影响力。例如，2022年5月，宾州大学的个人化细胞疗法已被核准用于治疗復发或难治性滤泡性淋巴瘤。

此外，2021年4月，百时美施贵宝宣布美国FDA核准了Brayange (lysocabtagene malaleucel)，这是一种新型 CAR T 疗法，用于治疗成人 R/R 大 B 细胞淋巴瘤患者。在 3L+LBCL 的关键临床试验 TRANSCEND NHL 001 中，Breyanzi 表现出 73% 的整体缓解率和 54% 的完全缓解 (CR)。

细胞治疗市场报告亮点

  • 由于危及生命的併发症的风险较低且该治疗方法的采用率不断增加，自体细胞疗法细分市场在 2023 年占据了市场的最大销售份额，达到 91.22%。
  • 由于高定价和干细胞库的成长等因素，同种异体治疗领域预计将在未来几年显着成长。此外，许多公司正准备将业务转向同种异体细胞治疗产品开发。
  • 由于越来越多地采用先进的细胞疗法来治疗各种类型的癌症，癌症治疗领域在 2023 年获得了最大的市场占有率。
  • 细胞疗法也被考虑用于肌肉骨骼疾病，并且具有巨大的市场成长潜力。
  • 北美由于其强大的法律规范、国际细胞治疗协会等机构的存在以及主要营运公司的存在而主导了市场。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章市场变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 附随市场前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 产业分析工具
    • 波特五力分析
    • PESTEL分析
    • COVID-19感染疾病的影响分析

第四章细胞治疗市场分类：治疗类型估计与趋势分析

  • 同种异体细胞疗法
    • 同种异体细胞疗法的全球市场，2018-2030
    • 干细胞疗法
    • 非干细胞疗法
  • 自体细胞疗法
    • 2018-2030年全球自体细胞治疗市场
    • 干细胞疗法
    • 非干细胞疗法

第五章细胞治疗市场分类：治疗面积估计与趋势分析

  • 细胞治疗市场：治疗领域波动分析
  • 肿瘤学
    • 肿瘤细胞治疗的全球市场，2018-2030
  • 心血管疾病（CVD）
    • 心血管疾病细胞疗法的全球市场
  • 肌肉骨骼疾病
    • 治疗肌肉骨骼疾病的细胞疗法的全球市场，2018-2030
  • 皮肤科
    • 皮肤科治疗细胞疗法的全球市场，2018-2030
  • 其他的
    • 其他治疗方法的全球细胞治疗市场，2018-2030

第六章 细胞治疗市场分类：区域估计与趋势分析

  • 北美洲
  • 欧洲
  • 亚太地区
  • 世界其他地区

第七章 竞争形势

  • 公司分类
  • 策略规划
  • 2023 年企业市场分析
  • 公司简介/名单
    • Novartis AG
    • Gilead Sciences, Inc.
    • Bristol-Myers Squibb Company
    • Johnson &Johnson Services, Inc
    • JCR Pharmaceuticals Co., Ltd.
    • JW Therapeutics
    • Atara Biotherapeutics
    • MEDIPOST
    • Anterogen Co., Ltd.
    • S. BIOMEDICS
Product Code: GVR-2-68038-701-8

Cell Therapy Market Growth & Trends:

The global cell therapy market size is expected to reach USD 20.07 billion by 2030, expanding at a CAGR of 22.66% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market players are witnessing an increasing interest in the development of advanced therapies that are based on tissue, genes, or cells. Research communities and companies continue to make large investments in the culturing and isolation of a broad range of cell types, such as keratinocytes, chondrocytes, cartilage, stem, dermal papilla, & epithelial cells for the development of novel therapies.

Regulatory authorities such as FDA play a crucial role in the growth of the market by undertaking initiatives related to the development and approval of advanced treatment development as well as restriction of unregulated treatments. In addition, direct cellular reprogramming is attracting interest as a cutting-edge treatment approach because of its advantages such as efficacy and security.

On the other hand, an increase in the number of clinical trials related to advanced therapies is expected to boost the market growth in the coming years. According to data obtained from the American Society of Gene & Cell Therapy, in Q1 2022, 32 non-genetically modified cellular therapeutics trials were initiated, and 69% of these were in the non-oncology arena. Moreover, according to ClinicalTrials.gov, more than 1800 active cellular therapies are under clinical trial.

Furthermore, key companies operating in the market are undertaking several strategic initiatives such as various agreements, new launches, and expansion to strengthen their market presence. For instance, in May 2022, the University of Pennsylvania's personalized cellular therapy was approved for the treatment of individuals with relapsed or resistant follicular lymphoma.

Moreover, in April 2021, Bristol Myers Squibb declared that U.S. FDA approved its Breyanzi (lisocabtagene maraleucel), a novel CAR T treatment for adults with R/R large B-cell lymphoma. In the pivotal trial for 3L+ LBCL, TRANSCEND NHL 001, Breyanzi showed a 73% overall response rate and a 54% complete response (CR) rate.

Cell Therapy Market Report Highlights:

  • The autologous therapy segment dominated the market with the largest revenue share of 91.22% in 2023, owing to increasing adoption of this therapy type coupled with lower risk of life-threatening complications
  • The allogenic therapy segment is expected to grow significantly in the coming years owing to factors such as high pricing and growth in stem cell banking. Moreover, many companies are preparing to shift their business toward allogenic cell therapy product development
  • Oncology therapeutic area captured the largest market share in 2023, owing to the increasing adoption of advanced cell therapies in the treatment of various types of cancers
  • Cell therapy are also under the investigation for musculoskeletal disorders and has great potential for market growth
  • North America dominated the market owing to the strong regulatory framework, presence of bodies like the International Society for Cellular Therapy, and presence of key operating companies

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Therapy Type Segment
    • 1.1.2. Therapeutic Area Segment
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources
    • 1.3.4. Primary Research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List Of Secondary Sources
  • 1.8. List Of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Landscape Insights

Chapter 3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Outlook
    • 3.1.2 Ancillary Market Outlook
  • 3.2 Market Dynamics
    • 3.2.1 Market Driver Analysis
      • 3.2.1.1 Rise In The Number Of Clinical Studies Pertaining To The Development Of Cellular Therapies
      • 3.2.1.2 Rising Adoption Of Regenerative Medicine
      • 3.2.1.3 Introduction Of Novel Platforms And Technologies
    • 3.2.2 Market Restraint Analysis
      • 3.2.2.1 Ethical Concerns Related To Stem Cell Research
      • 3.2.2.2 Clinical Issues Pertaining To Development & Implementation Of Cell Therapy
  • 3.3 Industry Analysis Tools
    • 3.3.1 Porter's Five Forces Analysis
    • 3.3.2 PESTEL Analysis
    • 3.3.3 COVID-19 Impact Analysis

Chapter 4 Cell Therapy Market Categorization: Therapy Type Estimates & Trend Analysis

  • 4.1 Allogeneic Cell Therapy
    • 4.1.1 Global Allogeneic Cell Therapy Market, 2018 - 2030 (USD Billion)
    • 4.1.2 Stem Cell Therapies
      • 4.1.2.1 Global Allogeneic Cell Therapy Market For Stem Cell Therapies, 2018 - 2030 (USD Billion)
      • 4.1.2.2 Hematopoeitic Stem Cell Therapies
      • 4.1.2.2.1 Global Allogeneic Cell Therapy Market For Hematopoeitic Stem Cell Therapies, 2018 - 2030 (USD Billion)
      • 4.1.2.3 Mesenchymal Stem Cell Therapies
      • 4.1.2.3.1 Global Allogeneic Cell Therapy Market For Mesenchymal Stem Cell Therapies, 2018 - 2030 (USD Billion)
    • 4.1.3 Non-Stem Cell Therapies
      • 4.1.3.1 Global Allogeneic Cell Therapy Market For Non-Stem Cell Therapies, 2018 - 2030 (USD Billion)
      • 4.1.3.2 Keratinocytes & Fibroblast-Based Therapies
      • 4.1.3.2.1 Global Allogeneic Cell Therapy Market For Keratinocytes & Fibroblast-Based Therapies, 2018 - 2030 (USD Billion)
      • 4.1.3.3 Others
      • 4.1.3.3.1 Global Allogeneic Cell Therapy Market For Other Non-Stem Cell Therapies, 2018 - 2030 (USD Billion)
  • 4.2 Autologous Cell Therapy
    • 4.2.1 Global Autologous Cell Therapy Market, 2018 - 2030 (USD Billion)
    • 4.2.2 Stem Cell Therapy
      • 4.2.2.1 Global Autologous Cell Therapy Market For Stem Cell Therapy, 2018 - 2030 (USD Billion)
      • 4.2.2.2 BM, Blood, & Umbilical Cord-Derived Stem Cells
      • 4.1.2.2.1 Global Autologous Cell Therapy Market For BM, Blood, & Umbilical Cord-Derived Stem Cells, 2018 - 2030 (USD Billion)
      • 4.2.2.3 Adipose Derived Cells
      • 4.1.2.3.1 Global Autologous Cell Therapy Market For Adipose Derived Cells, 2018 - 2030 (USD Billion)
      • 4.2.2.4 Others
      • 4.2.2.4.1 Global Autologous Cell Therapy Market For Other Therapies, 2018 - 2030 (USD Billion)
    • 4.2.3 Non-Stem Cell Therapy
      • 4.2.3.1 Global Autologous Cell Therapy Market For Non-Stem Cell Therapy, 2018 - 2030 (USD Billion)
      • 4.2.3.2 T-Cell Therapies
      • 4.2.3.2.1 Global Autologous Cell Therapies Market For T-Cell Therapy, 2018 - 2030 (USD Billion)
      • 4.2.4.2.2 CAR-T Cell Therapy
      • 4.2.4.2.2.1 Global Autologous Cell Therapy Market For CAR-T Cell Therapy, 2018 - 2030 (USD Billion)
      • 4.2.4.2.3 T-Cell Receptor (TCR)
      • 4.2.4.2.3.1 Global Autologous Cell Therapy Market For T-Cell Receptor (TCR), 2018 - 2030 (USD Billion)
      • 4.2.3.3 Others
      • 4.2.3.3.1 Global Autologous Cell Therapies Market For Other Autologous Non-Stem Cell Therapies, 2018 - 2030 (USD Billion)

Chapter 5 Cell Therapy Market Categorization: Therapeutic Area Estimates & Trend Analysis

  • 5.1 Cell Therapy Market: Therapeutic Area Movement Analysis
  • 5.2 Oncology
    • 5.2.1 Global Cell Therapy Market For Oncology Therapies, 2018 - 2030 (USD Million)
  • 5.3 Cardiovascular Disease (CVD)
    • 5.3.1 Global Cell Therapy Market For Cardiovascular Disease (CVD) Therapies, 2018 - 2030 (USD Million)
  • 5.4 Musculoskeletal Disorders
    • 5.4.1 Global Cell Therapy Market For Musculoskeletal Disorders Therapies, 2018 - 2030 (USD Million)
  • 5.5 Dermatology
    • 5.5.1 Global Cell Therapy Market For Dermatology Therapies, 2018 - 2030 (USD Million)
  • 5.6 Others
    • 5.6.1 Global Cell Therapy Market For Other Therapies, 2018 - 2030 (USD Million)

Chapter 6 Cell Therapy Market Categorization: Regional Estimates & Trend Analysis

  • 6.1 North America
    • 6.1.1 North America Cell Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.1.2 U.S.
      • 6.1.2.1 Key Country Dynamics
      • 6.1.2.2 Target Disease Prevalence
      • 6.1.2.3 Competitive Scenario
      • 6.1.2.4 Regulatory Framework
      • 6.1.2.6 U.S. Cell Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.1.3 Canada
      • 6.1.3.1 Key Country Dynamics
      • 6.1.3.2 Target Disease Prevalence
      • 6.1.3.3 Competitive Scenario
      • 6.1.3.4 Regulatory Framework
      • 6.1.3.6 Canada Cell Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.2 Europe
    • 6.2.1 Europe Cell Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2 Germany
      • 6.2.2.1 Key Country Dynamics
      • 6.2.2.2 Target Disease Prevalence
      • 6.2.2.3 Competitive Scenario
      • 6.2.2.4 Regulatory Framework
      • 6.2.2.6 Germany Cell Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.3 UK
      • 6.2.3.1 Key Country Dynamics
      • 6.2.3.2 Target Disease Prevalence
      • 6.2.3.3 Competitive Scenario
      • 6.2.3.4 Regulatory Framework
      • 6.2.3.6 UK Cell Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.4 Switzerland
      • 6.2.4.1 Key Country Dynamics
      • 6.2.4.2 Target Disease Prevalence
      • 6.2.4.3 Competitive Scenario
      • 6.2.4.4 Regulatory Framework
      • 6.2.4.6 Switzerland Cell Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.3 Asia Pacific
    • 6.3.1 Asia Pacific Cell Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2 Japan
      • 6.3.2.1 Target Disease Prevalence
      • 6.3.2.2 Competitive Scenario
      • 6.3.2.3 Regulatory Framework
      • 6.3.2.5 Japan Cell Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3 China
      • 6.3.3.1 Target Disease Prevalence
      • 6.3.3.2 Competitive Scenario
      • 6.3.3.3 Regulatory Framework
      • 6.3.3.5 China Cell Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4 India
      • 6.3.4.1 Target Disease Prevalence
      • 6.3.4.2 Competitive Scenario
      • 6.3.4.3 Regulatory Framework
      • 6.3.4.5 India Cell Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.3.5 South Korea
      • 6.3.5.1 Target Disease Prevalence
      • 6.3.5.2 Competitive Scenario
      • 6.3.5.3 Regulatory Framework
      • 6.3.5.5 South Korea Cell Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.4 Rest Of The World
    • 6.4.1 Rest Of The World Cell Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 7 Competitive Landscape

  • 7.1 Company Categorization
  • 7.2 Strategy Mapping
  • 7.3 Company Market Position Analysis, 2023
  • 7.4 Company Profiles/Listing
    • 7.4.1 Novartis AG
      • 7.4.1.1 Company Overview
      • 7.4.1.4 Financial Performance
      • 7.4.1.3 Product Benchmarking
      • 7.4.1.4 Strategic Initiatives
    • 7.4.2 Gilead Sciences, Inc.
      • 7.4.2.1 Company Overview
      • 7.4.2.2 Financial Performance
      • 7.4.2.3 Product Benchmarking
      • 7.4.2.4 Strategic Initiatives
    • 7.4.3 Bristol-Myers Squibb Company
      • 7.4.3.1 Company Overview
      • 7.4.3.2 Financial Performance
      • 7.4.3.3 Product Benchmarking
      • 7.4.3.4 Strategic Initiatives
    • 7.4.4 Johnson & Johnson Services, Inc
      • 7.4.4.1 Company Overview
      • 7.4.4.2 Financial Performance
      • 7.4.4.3 Product Benchmarking
      • 7.4.4.4 Strategic Initiatives
    • 7.4.5 JCR Pharmaceuticals Co., Ltd.
      • 7.4.5.1 Company Overview
      • 7.4.5.2 Financial Performance
      • 7.4.5.3 Product Benchmarking
      • 7.4.5.4 Strategic Initiatives
    • 7.4.6 JW Therapeutics
      • 7.4.6.1 Company Overview
      • 7.4.6.2 Financial Performance
      • 7.4.6.3 Product Benchmarking
      • 7.4.6.4 Strategic Initiatives
    • 7.4.7 Atara Biotherapeutics
      • 7.4.7.1 Company Overview
      • 7.4.7.2 Financial Performance
      • 7.4.7.3 Product Benchmarking
      • 7.4.7.4 Strategic Initiatives
    • 7.4.8 MEDIPOST
      • 7.4.8.1 Company Overview
      • 7.4.8.2 Financial Performance
      • 7.4.8.3 Product Benchmarking
      • 7.4.8.4 Strategic Initiatives
    • 7.4.9 Anterogen Co., Ltd.
      • 7.4.9.1 Company Overview
      • 7.4.9.2 Financial Performance
      • 7.4.9.3 Product Benchmarking
      • 7.4.9.4 Strategic Initiatives
    • 7.4.10 S. BIOMEDICS
      • 7.4.10.1 Company Overview
      • 7.4.10.2 Financial Performance
      • 7.4.10.3 Product Benchmarking
      • 7.4.10.4 Strategic Initiatives

List of Tables

  • Table 1 List Of Secondary Sources
  • Table 2 Global Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
  • Table 3 Global Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 4 Global Cell Therapy Market By Region, 2018 - 2030 (USD Million)
  • Table 5 North America Cell Therapy Market By Country, 2018 - 2030 (USD Million)
  • Table 6 North America Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
  • Table 7 North America Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 8 U.S. Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
  • Table 9 U.S. Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 10 Canada Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
  • Table 11 Canada Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 12 Europe Cell Therapy Market By Country, 2018 - 2030 (USD Million)
  • Table 13 Europe Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
  • Table 14 Europe Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 15 Germany Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
  • Table 16 Germany Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 17 UK Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
  • Table 18 UK Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 19 Switzerland Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
  • Table 20 Switzerland Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 21 Asia Pacific Cell Therapy Market By Country, 2018 - 2030 (USD Million)
  • Table 22 Asia Pacific Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
  • Table 23 Asia Pacific Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 24 China Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
  • Table 25 China Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 26 Japan Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
  • Table 27 Japan Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 28 India Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
  • Table 29 India Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 30 South Korea Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
  • Table 31 South Korea Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 32 Rest Of The World Cell Therapy Market By Therapy Type, 2018 - 2030 (USD Million)
  • Table 33 Rest Of The World Cell Therapy Market By Therapeutic Area, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Cell Therapy Market, Market Segmentation
  • Fig. 7 Market Driver Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Analysis (Current & Future Impact)
  • Fig. 9 PESTEL Analysis
  • Fig. 10 Porter's Five Forces Analysis
  • Fig. 11 Global Cell Therapy Market: Therapy Type Key Takeaways
  • Fig. 12 Global Cell Therapy Market: Therapy Type Movement Analysis
  • Fig. 13 Global Cell Therapy Market For Allogeneic Therapies, 2018 - 2030 (USD Million)
  • Fig. 14 Global Cell Therapy Market For Stem Cell Therapies, 2018 - 2030 (USD Million)
  • Fig. 15 Global Cell Therapy Market For Hematopoetic Stem Cell Therapies, 2018 - 2030 (USD Million)
  • Fig. 16 Global Cell Therapy Market For Mesenchymal Stem Cell Therapies, 2018 - 2030 (USD Million)
  • Fig. 17 Global Cell Therapy Market For Non-Stem Cell Therapies, 2018 - 2030 (USD Million)
  • Fig. 18 Global Cell Therapy Market For Keratinocyte & Fibroblast-Based Therapies, 2018 - 2030 (USD Million)
  • Fig. 19 Global Cell Therapy Market For Other Non-Stem Cell Therapies, 2018 - 2030 (USD Million)
  • Fig. 20 Global Cell Therapy Market For Autologous Cell Therapies, 2018 - 2030 (USD Million)
  • Fig. 21 Global Cell Therapy Market For Autologous Stem-Cell Therapies, 2018 - 2030 (USD Million)
  • Fig. 22 Global Cell Therapy Market For BM, Blood, & Umbilical Cord-Derived Stem Cell Therapies, 2018 - 2030 (USD Million)
  • Fig. 23 Global Cell Therapy Market For Adipose Derived Cells, 2018 - 2030 (USD Million)
  • Fig. 24 Global Cell Therapy Market For Others, 2018 - 2030 (USD Million)
  • Fig. 25 Global Cell Therapy Market For Autologous Non-Stem Cell Therapies, 2018 - 2030 (USD Million)
  • Fig. 26 Global Cell Therapy Market For T-Cell Therapies, 2018 - 2030 (USD Million)
  • Fig. 27 Global Cell Therapy Market For CAR T Cell Therapy, 2018 - 2030 (USD Million)
  • Fig. 28 Global Cell Therapy Market For T Cell Receptor (TCR)-Based, 2018 - 2030 (USD Million)
  • Fig. 29 Global Cell Therapy Market For Other Autologous Non Stem-Cell Therapies, 2018 - 2030 (USD Million)
  • Fig. 30 Global Cell Therapy Market: Therapeutic Area Key Takeaways
  • Fig. 31 Global Cell Therapy Market: Therapeutic Area Movement Analysis
  • Fig. 32 Global Cell Therapy Market For Oncology, 2018 - 2030 (USD Million)
  • Fig. 33 Global Cell Therapy Market For Cardiovascular Disease (CVD), 2018 - 2030 (USD Million)
  • Fig. 34 Global Cell Therapy Market For Musculoskeletal Disorders, 2018 - 2030 (USD Million)
  • Fig. 35 Global Cell Therapy Market For Dermatology, 2018 - 2030 (USD Million)
  • Fig. 36 Global Cell Therapy Market For Others, 2018 - 2030 (USD Million)
  • Fig. 37 Regional Outlook, 2023 & 2030
  • Fig. 38 North America Cell Therapy Market, 2018 - 2030 (USD Million)
  • Fig. 39 U.S. Cell Therapy Market, 2018 - 2030 (USD Million)
  • Fig. 40 Canada Cell Therapy Market, 2018 - 2030 (USD Million)
  • Fig. 41 Europe Cell Therapy Market, 2018 - 2030 (USD Million)
  • Fig. 42 Germany Cell Therapy Market, 2018 - 2030 (USD Million)
  • Fig. 43 UK Cell Therapy Market, 2018 - 2030 (USD Million)
  • Fig. 44 Switzerland Cell Therapy Market, 2018 - 2030 (USD Million)
  • Fig. 45 Asia Pacific Cell Therapy Market, 2018 - 2030 (USD Million)
  • Fig. 46 Japan Cell Therapy Market, 2018 - 2030 (USD Million)
  • Fig. 47 China Cell Therapy Market, 2018 - 2030 (USD Million)
  • Fig. 48 India Cell Therapy Market, 2018 - 2030 (USD Million)
  • Fig. 49 South Korea Cell Therapy Market, 2018 - 2030 (USD Million)
  • Fig. 50 Rest Of The World Cell Therapy Market, 2018 - 2030 (USD Million)